Travere Therapeutics, Inc. (TVTX)
65.22
-0.49
(-0.75%)
USD |
NASDAQ |
Aug 24, 16:00
65.22
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Total Assets (Quarterly) : 799.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 799.36M |
| March 31, 2026 | 555.19M |
| December 31, 2025 | 605.19M |
| September 30, 2025 | 538.58M |
| June 30, 2025 | 555.31M |
| March 31, 2025 | 548.80M |
| December 31, 2024 | 594.12M |
| September 30, 2024 | 504.41M |
| June 30, 2024 | 551.12M |
| March 31, 2024 | 663.55M |
| December 31, 2023 | 788.91M |
| September 30, 2023 | 832.85M |
| June 30, 2023 | 736.43M |
| March 31, 2023 | 808.23M |
| December 31, 2022 | 672.58M |
| September 30, 2022 | 726.22M |
| June 30, 2022 | 779.49M |
| March 31, 2022 | 828.40M |
| December 31, 2021 | 776.63M |
| September 30, 2021 | 775.08M |
| June 30, 2021 | 746.77M |
| March 31, 2021 | 764.04M |
| December 31, 2020 | 607.44M |
| September 30, 2020 | 692.22M |
| June 30, 2020 | 678.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 573.06M |
| December 31, 2019 | 604.80M |
| September 30, 2019 | 613.82M |
| June 30, 2019 | 647.57M |
| March 31, 2019 | 667.67M |
| December 31, 2018 | 741.87M |
| September 30, 2018 | 716.19M |
| June 30, 2018 | 491.14M |
| March 31, 2018 | 500.79M |
| December 31, 2017 | 537.16M |
| September 30, 2017 | 520.51M |
| June 30, 2017 | 507.13M |
| March 31, 2017 | 510.38M |
| December 31, 2016 | 567.56M |
| September 30, 2016 | 532.42M |
| June 30, 2016 | 533.97M |
| March 31, 2016 | 507.10M |
| December 31, 2015 | 512.40M |
| September 30, 2015 | 511.63M |
| June 30, 2015 | 425.14M |
| March 31, 2015 | 415.99M |
| December 31, 2014 | 135.47M |
| September 30, 2014 | 145.93M |
| June 30, 2014 | 155.54M |
| March 31, 2014 | 94.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| Insmed, Inc. | 2.103B |
| United Therapeutics Corp. | 7.220B |
| Krystal Biotech, Inc. | 1.501B |
| Relay Therapeutics, Inc. | 967.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 774.84M |
| Shareholders Equity (Quarterly) | 24.52M |
| Debt to Equity Ratio | 25.16 |
| Current Ratio | 4.046 |
| Net Debt Paydown Yield | -0.81% |